EVAX
Evaxion
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
EVAX fundamentals
Evaxion (EVAX) released its earnings on May 27, 2025: revenue was 0 (YoY -100.00%), missed estimates; EPS was -0.01 (YoY -133.33%), missed estimates.
Revenue / YoY
0
-100.00%
EPS / YoY
-0.01
-133.33%
Report date
May 27, 2025
EVAX Earnings Call Summary for Q1,2025
- Merck Option Exercise Catalyst: Potential $10M H2 2025 milestone for EVX-B2/B3 compounds.
- EVX-01 Immunogenicity: 80% target immune response rate, CD4 T-cell dominance, and CD8 response in half of patients.
- Financial Strength: $17.8M cash (mid-2026 runway) and $10.3M equity, meeting NASDAQ requirements.
- Pipeline Momentum: ERV vaccine lead selection in H2, first infectious disease candidate shortlisted.
- Market Risk: Macro uncertainty delays 2025 deal execution, though two-deal target remains intact.
EPS
Revenue
Revenue & Expenses
Key Indicators
Evaxion (EVAX) key financial stats and ratios, covering profitability, financial health, and leverage.
Evaxion (EVAX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Evaxion (EVAX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Evaxion (EVAX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Evaxion (EVAX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Evaxion (EVAX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
How were Evaxion’s latest financial results overall?What were the key takeaways from Evaxion’s earnings call?What is the revenue and EPS growth rate for Evaxion year over year?What is the market’s earnings forecast for Evaxion next quarter?What is Evaxion’s gross profit margin?Did Evaxion beat or miss consensus estimates last quarter?What does Evaxion do and what are its main business segments?What guidance did Evaxion’s management provide for the next earnings period?